Literature DB >> 16870791

qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States.

A Robicsek1, J Strahilevitz, D F Sahm, G A Jacoby, D C Hooper.   

Abstract

We screened 313 ceftazidime-resistant Enterobacteriaceae isolates obtained in the United States from 1999 to 2004 for all three known qnr genes. A qnr gene was present in 20% of Klebsiella pneumoniae isolates, 31% of Enterobacter sp. isolates, and 4% of Escherichia coli isolates. qnrA and qnrB occurred with equivalent frequencies and, except for qnrB in enterobacters, were stable over time. qnrS was absent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870791      PMCID: PMC1538681          DOI: 10.1128/AAC.01647-05

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV.

Authors:  John H Tran; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.

Authors:  John H Tran; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica.

Authors:  Kathryn Gay; Ari Robicsek; Jacob Strahilevitz; Chi Hye Park; George Jacoby; Timothy J Barrett; Felicita Medalla; Tom M Chiller; David C Hooper
Journal:  Clin Infect Dis       Date:  2006-06-20       Impact factor: 9.079

4.  qnrB, another plasmid-mediated gene for quinolone resistance.

Authors:  George A Jacoby; Kelley E Walsh; Debra M Mills; Victoria J Walker; Herin Oh; Ari Robicsek; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Quinolone resistance from a transferable plasmid.

Authors:  L Martínez-Martínez; A Pascual; G A Jacoby
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

6.  Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b.

Authors:  Mami Hata; Masahiro Suzuki; Masakado Matsumoto; Masao Takahashi; Katsuhiko Sato; Shiro Ibe; Kenji Sakae
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

7.  Mechanism of plasmid-mediated quinolone resistance.

Authors:  John H Tran; George A Jacoby
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

Review 8.  Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae.

Authors:  Patrice Nordmann; Laurent Poirel
Journal:  J Antimicrob Chemother       Date:  2005-07-14       Impact factor: 5.790

  8 in total
  170 in total

1.  Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region.

Authors:  Gisele Peirano; Akke K van der Bij; Daniel B Gregson; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  ISEcp1-mediated transposition and homologous recombination can explain the context of bla(CTX-M-62) linked to qnrB2.

Authors:  Zhiyong Zong; Sally R Partridge; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

3.  High level of quinolone resistance in Escherichia coli from healthy chicken broilers.

Authors:  V Kmet; M Kmetová
Journal:  Folia Microbiol (Praha)       Date:  2010-03-25       Impact factor: 2.099

4.  Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.

Authors:  Chi Hye Park; Ari Robicsek; George A Jacoby; Daniel Sahm; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

5.  Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital.

Authors:  Laurent Poirel; Cécile Leviandier; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

6.  Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005.

Authors:  Jacob Strahilevitz; Dalia Engelstein; Amos Adler; Violeta Temper; Allon E Moses; Colin Block; Ari Robicsek
Journal:  Antimicrob Agents Chemother       Date:  2007-05-25       Impact factor: 5.191

7.  Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.

Authors:  Corinne Arpin; Laure Coulange; Véronique Dubois; Catherine André; Isabelle Fischer; Sophie Fourmaux; Frédéric Grobost; Jacqueline Jullin; Brigitte Dutilh; Jean-Francois Couture; Patrick Noury; Isabelle Lagrange; Aline Ducastaing; Henri-Pierre Doermann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2007-06-25       Impact factor: 5.191

Review 8.  Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.

Authors:  Agnese Lupo; Krisztina M Papp-Wallace; Parham Sendi; Robert A Bonomo; Andrea Endimiani
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-03       Impact factor: 2.803

9.  Characterization of small ColE-like plasmids mediating widespread dissemination of the qnrB19 gene in commensal enterobacteria.

Authors:  Lucia Pallecchi; Eleonora Riccobono; Samanta Sennati; Antonia Mantella; Filippo Bartalesi; Christian Trigoso; Eduardo Gotuzzo; Alessandro Bartoloni; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

10.  Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.

Authors:  Hyunjoo Pai; Mi-Ran Seo; Tae Yeal Choi
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.